Literature DB >> 10517968

Physostigmine antagonizes ketamine-induced noradrenaline release from the medial prefrontal cortex in rats.

T Kubota1, K Hirota, N Anzawa, H Yoshida, T Kushikata, A Matsuki.   

Abstract

Physostigmine is known to antagonize ketamine anesthesia. In this study, effects of physostigmine (0.1 mg kg(-1) i.p.) on ketamine (100 mg kg(-1) i.p.)-induced anesthesia time and noradrenaline release from the medial prefrontal cortex in rats were examined. Ketamine produced anesthesia for 27+/-1 min and increased noradrenaline release to 405% of the basal. Physostigmine significantly reduced anesthesia time to 23+/-1 min (p<0.05), and noradrenaline to 248% (p<0.05). Therefore, noradrenaline release may play an important role in ketamine anesthesia.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10517968     DOI: 10.1016/s0006-8993(99)01793-x

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  3 in total

Review 1.  Rodent ketamine depression-related research: Finding patterns in a literature of variability.

Authors:  Andrew J Polis; Paul J Fitzgerald; Pho J Hale; Brendon O Watson
Journal:  Behav Brain Res       Date:  2019-08-13       Impact factor: 3.332

2.  Interaction between Mesocortical and Mesothalamic Catecholaminergic Transmissions Associated with NMDA Receptor in the Locus Coeruleus.

Authors:  Motohiro Okada; Kouji Fukuyama
Journal:  Biomolecules       Date:  2020-07-01

Review 3.  In vivo electrophysiological recordings of the effects of antidepressant drugs.

Authors:  Paul J Fitzgerald; Brendon O Watson
Journal:  Exp Brain Res       Date:  2019-05-11       Impact factor: 1.972

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.